Suzanne Marie Noakes

Array ( [id] => 8990350 [patent_doc_number] => 20130217631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'COLLAGEN MIXTURE AND METHOD OF MAKING THE SAME' [patent_app_type] => utility [patent_app_number] => 13/848389 [patent_app_country] => US [patent_app_date] => 2013-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 1156 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13848389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9448982 [patent_doc_number] => 20140120151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-01 [patent_title] => 'Gelatin Sponge Comprising an Active Ingredient, Its Preparation and Use' [patent_app_type] => utility [patent_app_number] => 13/847898 [patent_app_country] => US [patent_app_date] => 2013-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17487 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13847898 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13968319 [patent_doc_number] => 10213493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Protein to promote blood vessel growth and uses thereof [patent_app_type] => utility [patent_app_number] => 14/385041 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 9 [patent_no_of_words] => 4574 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14385041 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9589105 [patent_doc_number] => 08778646 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-07-15 [patent_title] => 'Method for treatment of microorganisms during propagation, conditioning and fermentation using hops acid extracts and organic acid' [patent_app_type] => utility [patent_app_number] => 13/833522 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 6918 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13833522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983370 [patent_doc_number] => 09029076 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Tissue preservation and fixation method' [patent_app_type] => utility [patent_app_number] => 13/836995 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 35 [patent_no_of_words] => 15208 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13836995 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9692061 [patent_doc_number] => 08822656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-02 [patent_title] => 'Manufacture of factor H (FH) and FH-derivatives from plasma' [patent_app_type] => utility [patent_app_number] => 13/830918 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 37590 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10864140 [patent_doc_number] => 08889838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-18 [patent_title] => 'Removal of serine proteases by treatment with finely divided silicon dioxide' [patent_app_type] => utility [patent_app_number] => 13/830815 [patent_app_country] => US [patent_app_date] => 2013-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 71593 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13830815 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916791 [patent_doc_number] => 20130178416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'FUSION PEPTIDE THERAPEUTIC COMPOSITIONS' [patent_app_type] => utility [patent_app_number] => 13/795992 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 32658 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795992 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8916334 [patent_doc_number] => 20130177958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'XYLOSE UTILIZING ZYMOMONAS MOBILIS WITH IMPROVED ETHANOL PRODUCTION IN BIOMASS HYDROLYSATE MEDIUM' [patent_app_type] => utility [patent_app_number] => 13/795148 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14481 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10506336 [patent_doc_number] => 09234203 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Stabilized recombinant expression plasmid vector in hafnia alvei and applications thereof' [patent_app_type] => utility [patent_app_number] => 13/795949 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6835 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 125 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13795949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355020 [patent_doc_number] => 08673553 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Recombinant bacteriophage and methods for their use' [patent_app_type] => utility [patent_app_number] => 13/797833 [patent_app_country] => US [patent_app_date] => 2013-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 29 [patent_no_of_words] => 30061 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13797833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9888789 [patent_doc_number] => 08975042 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-10 [patent_title] => 'Fluorescent and colored proteins and methods for using them' [patent_app_type] => utility [patent_app_number] => 13/791821 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 30596 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13791821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263292 [patent_doc_number] => 20150148288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'Toxic Peptide Production, Peptide Expression in Plants and Combinations of Cysteine Rich Peptides' [patent_app_type] => utility [patent_app_number] => 14/383841 [patent_app_country] => US [patent_app_date] => 2013-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 71430 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831085 [patent_doc_number] => 08859250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'Crystal structure of glutaminyl cyclase' [patent_app_type] => utility [patent_app_number] => 13/777871 [patent_app_country] => US [patent_app_date] => 2013-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 188 [patent_figures_cnt] => 192 [patent_no_of_words] => 17252 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13777871 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9582455 [patent_doc_number] => 08772458 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-08 [patent_title] => 'Crystalline anti-hTNFalpha antibodies' [patent_app_type] => utility [patent_app_number] => 13/774706 [patent_app_country] => US [patent_app_date] => 2013-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 23955 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13774706 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805742 [patent_doc_number] => 20150017686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'METHODS FOR REDUCING MANNOSYLTRANSFERASE ACTIVITY IN LOWER EUKARYOTES' [patent_app_type] => utility [patent_app_number] => 14/375800 [patent_app_country] => US [patent_app_date] => 2013-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 32111 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10136160 [patent_doc_number] => 09169473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-27 [patent_title] => 'Polypeptides having xylanase activity and polynucleotides encoding same' [patent_app_type] => utility [patent_app_number] => 13/765267 [patent_app_country] => US [patent_app_date] => 2013-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33207 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9222482 [patent_doc_number] => 20140017256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'CRYSTALLINE ANTI-HUMAN IL-12 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 13/762171 [patent_app_country] => US [patent_app_date] => 2013-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 25541 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13762171 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8963465 [patent_doc_number] => 20130203067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'DETECTION OF INTRACELLULAR BINDING EVENTS BY MEASURING PROTEIN ABUNDANCE' [patent_app_type] => utility [patent_app_number] => 13/759691 [patent_app_country] => US [patent_app_date] => 2013-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16742 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13759691 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9812105 [patent_doc_number] => 20150024050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-22 [patent_title] => 'DRY POWDER FORMULATIONS OF DNASE I' [patent_app_type] => utility [patent_app_number] => 14/375485 [patent_app_country] => US [patent_app_date] => 2013-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 37891 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14375485 [rel_patent_id] =>[rel_patent_doc_number] =>)